Introduction
The claims that hail the advent of new drugs have sometimes testified to the enthusiasm of the promoters rather than to the actual merits of their products and may have justified the cynical advice to use a new medicine before it has lost its efficacy. Even when the initial appraisal of an active chemical compound has proved to be correct it often has had to be modified later because of the development of drug resistance or the arrival of a newer and even more effective remedy. It was natural, therefore, that many expected that sooner or later metronidazole would be eclipsed or would cease to give such high rates of cure.
The publication abroad of papers representing that metronidazole (Fiagyl) had begun to fail and rumours nearer home suggested the desirability of investigations designed to compare current cure rates in trichomoniasis with those obtained in the early 1960s. Accordingly a retrospective study was made of cases treated in the closed community of Holloway Prison, and this paper embodies the findings.
In order to compare the "response rate" of patients treated with metronidazole for trichomonal vaginitis in more recent years with that of previous years (Keighley, 1962) 
Results

EXCLUDED FROM ANALYSIS
Of the 583 cases documented 87 were excluded from the "cure rate" analysis.
(1) Seventy-four patients (12.7%) had less than two weeks' follow-up (2-10 days) (Table III) . All were negative for T. vaginalis on direct film at posttreatment examination. Of these, 62 showed immediate clinical response; inflammation and irritation had subsided and there was no discharge. In the other 12 patients some discharge persisted; most of these had concurrent infections or cervical erosion. These 74 patients were women on remand in custody, before reappearing at court, who did not return to the prison.
(2) Thirteen patients were negative for T. vaginalis on pretreatment direct film examination but were found to be positive on cervical cytology. After treatment with metronidazole smears were negative, but as no further cytology was undertaken the test of cure is taken as incomplete.
INCLUDED IN ANALYSIS
Response to Treatment.-Of the 496 cases taken into the cure rate assessment, 488 (98-3 %) were classified as "cures"; these were negative for T. vaginalis on direct film examination after one course of metronidazole and remained negative throughout the observation period. The length of observation in this group is shown in Table IV . Treatment Failures.-Eight patients were classed as "treatment failures" and re-treated with the same dosage of metronidazole. Of these, six received a second course (four responded to treatment, one left the prison, and one refused further treatment) and two required a third course (one was negative on direct film examination throughout but positive on cervical cytology on two occasions (first and fifth weeks) and became negative on cytology after a third course of metronidazole; the other was re-treated twice but left the prison before follow-up examination was carried out). Details and summary of the pathological results in these eight cases are given in Table V .
CLINICAL RESPONSE IN ALL CASES IN SURVEY
Before treatment 95 0/, of patients complained of a discharge and irritation; 30 (5%) had no complaints and were symptom-free. After treatment with metronidazole, inflammation and irritation subsided and discharge cleared within four weeks in 418 patients (71-70), ). In 61 a scanty discharge remained which cleared at varying periods up to 12 weeks. In 74 (12-7%',) some discharge persisted, mostly due to other complicating conditions (Table VI) . Time of examination after the start of treatment, when the patient was free of vaginal discharge, is shown in Table VI. ADVERSE REACTIONS There were no complaints of intolerance. I consider this to be due to the regular life of eating and sleeping and to the fact that the patient always received her tablets after a meal. 29-7 27-6 8-4 2-0 Antibiotics were never given concurrently with metronidazole; if a specific infection was present it was treated -before the trichomonal vaginitis.
ADDITIONAL DIAGNOSES
In 113 patients gonorrhoea as well as trichomonal vaginitis was present. Twenty-five had a concurrent candidial vaginitis for which they were given nystatin pessaries. Six patients were suffering from all three infections-that is, trichomonal gonorrhoeal, and candidial. Eight patients were treated topically with podophyllin for vaginal warts.
Conclusions
Finally, it is a good thing to pause and contemplate-the change that oral medication for trichomonal vaginitis has made in women's lives. 'Flagyl' is now taken as a matter of course, and a whole generation has no knowledge of the sufferings of women with trichomoniasis before its introductionthe indignities and discomfort of the perpetual local treatment, douches, paintings, insufflations, and insertions of pessaries, etc. All these. things women suffered for months and sometimes years on end, only to relapse when the treatment was discontinued. The results of this survey leave no doubt in my mind that metronidazole has not lost its efficacy and is still the drug of choice.
